Intelligence Platform
Patents
Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11723923
Methods of preparing T cells for T cell therapy
granted patentUS 11718647
Virus-like particles and methods of use
granted patentUS 11702417
Compounds for improving mRNA splicing
granted patentUS 11696922
Nanoparticle to target cancer
granted patentUS 11697676
Anti-human papillomavirus 16 E6 T cell receptors
granted patentUS 11692010
Compounds that bind to human immunodeficiency virus rev response element
granted patentUS 11686735
Systems and methods to identify and treat subjects at risk for obstetrical complications
granted patentUS 11680093
Monoclonal antibodies that specifically bind to matrilin 3 and their use
granted patentUS 11679128
Methods of producing enriched populations of tumor reactive T cells from peripheral blood
granted patentUS 11679151
Stabilized influenza hemagglutinin stem region trimers and uses thereof
granted patentUS 11672876
Imageable embolic microsphere
granted patentUS 11666663
Hexameric tetrahedral RNA nanostructures
granted patentUS 11667692
T cell receptors recognizing HLA-CW8 restricted mutated KRAS
granted patentUS 11661439
Peptide hydrogels and use thereof
granted patentUS 11655469
MicroRNAs and methods of their use
granted patentUS 11649218
C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the
granted patentUS 11642374
Intracellular genomic transplant and methods of therapy
granted patentUS 11642375
Intracellular genomic transplant and methods of therapy
granted patentUS 11633471
Compositions and methods for reducing serum triglycerides
granted patentUS 11634404
Selective D3 dopamine receptor agonists and methods of their use
granted patentUS 11634459
Chimeric reporter West Nile/dengue viruses and their use
granted patentUS 11617801
RP2 and RPGR vectors for treating X-linked retinitis pigmentosa
granted patentUS 11602559
HIV-1 Env fusion peptide immunogens and their use
granted patentUS 11591372
Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F p
granted